Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

Peptides and CCL11 and HMGB1 as differently expressed age-dependent proinflammatory biomarkers of ageing

Khavinson VK, Kuznik BI, Tarnovskaya SI, Linkova NS. Advances in Gerontology 2020

Document identifier
CEI-BR-058
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
Khavinson VK, Kuznik BI, Tarnovskaya SI, Linkova NS
Title
Peptides and CCL11 and HMGB1 as differently expressed age-dependent proinflammatory biomarkers of ageing
Source
Advances in Gerontology
Year
2020
Volume, issue, pages
10(1):1–8
Digital object identifier
10.1134/S2079057020010063
PubMed identifier
not held by the Institute
Record type
Journal article
Institute identifier
CEI-BR-058

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

DocumentSeries
Monograph: EpithalonCompound monograph
1 citing document.

§1.3Subject tags

epithalon ageing preclinical

Compound Evidence Institute · CEI-BR-058 · https://compoundevidence.com/bibliography/khavinson2020/ · retrieved 30 July 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.